$NYMX NYMOX PHARMACEUTICAL CORP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NYMOX PHARMACEUTICAL CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in NYMOX PHARMACEUTICAL CORP for free.

CIK Number: 0001018735
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NYMX
Company Address: 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA H4M 2V2

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert. It is aslo developing NX-1207 for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Market Capitalization: $174.27M
Prev close: $3.78
Average Daily Volume: 175,555
Days Low: $3.60
Year Low: $1.62
Year High: $5.79

NYMOX PHARMACEUTICAL CORP Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 04 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.675,00018,3503,082,5503.1 M to 3.1 M (+0.16 %)
Aug 04 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.795,00018,9503,077,5503.1 M to 3.1 M (+0.16 %)
Aug 01 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.675,00018,3503,072,5503.1 M to 3.1 M (+0.16 %)
Aug 01 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.725,00018,6003,067,5503.1 M to 3.1 M (+0.16 %)
Aug 01 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.775,00018,8503,062,5503.1 M to 3.1 M (+0.16 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP4.132,50010,3253,057,5503.1 M to 3.1 M (+0.08 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP4.091,0004,0903,055,0503.1 M to 3.1 M (+0.03 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.931,5005,8953,054,0503.1 M to 3.1 M (+0.05 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.921,0003,9203,052,5503.1 M to 3.1 M (+0.03 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.915001,9553,051,5503.1 M to 3.1 M (+0.02 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.991,5005,9853,051,0503 M to 3.1 M (+0.05 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.972,0007,9403,049,5503 M to 3 M (+0.07 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.951,0003,9503,047,5503 M to 3 M (+0.03 %)
Jul 07 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP3.945001,9703,046,5503 M to 3 M (+0.02 %)
Jun 29 2017NYMXNYMOX PHARMACEUTIC ...Robinson James GeorgeDirectorBuyP4.022,0008,0403,046,0503 M to 3 M (+0.07 %)

View all NYMOX PHARMACEUTICAL CORP insider transactions.